Gulf International Bank (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.77M | Buy |
19,636
+6,720
| +52% | +$3.13M | 0.2% | 92 |
|
|
2025
Q4 | $5.86M | Buy |
12,916
+37
| +0.3% | +$15.9K | 0.19% | 96 |
|
|
2025
Q3 | $5.04M | Sell |
12,879
-255
| -2% | -$107K | 0.17% | 110 |
|
|
2025
Q2 | $5.85M | Sell |
13,134
-1,774
| -12% | -$818K | 0.21% | 95 |
|
|
2025
Q1 | $7.23M | Sell |
14,908
-4,524
| -23% | -$2.11M | 0.25% | 82 |
|
|
2024
Q4 | $7.83M | Sell |
19,432
-916
| -5% | -$425K | 0.2% | 92 |
|
|
2024
Q3 | $9.46M | Sell |
20,348
-850
| -4% | -$408K | 0.24% | 76 |
|
|
2024
Q2 | $9.94M | Sell |
21,198
-1,324
| -6% | -$575K | 0.25% | 80 |
|
|
2024
Q1 | $9.41M | Buy |
22,522
+1,350
| +6% | +$571K | 0.24% | 90 |
|
|
2023
Q4 | $8.61M | Sell |
21,172
-2,443
| -10% | -$902K | 0.24% | 88 |
|
|
2023
Q3 | $8.21M | Sell |
23,615
-2,397
| -9% | -$838K | 0.23% | 89 |
|
|
2023
Q2 | $9.15M | Sell |
26,012
-7,789
| -23% | -$2.62M | 0.23% | 89 |
|
|
2023
Q1 | $10.6M | Sell |
33,801
-8,776
| -21% | -$2.63M | 0.22% | 95 |
|
|
2022
Q4 | $12.3M | Hold |
42,577
| – | – | 0.22% | 99 |
|
|
2022
Q3 | $12.3M | Sell |
42,577
-898
| -2% | -$258K | 0.23% | 87 |
|
|
2022
Q2 | $12.2M | Hold |
43,475
| – | – | 0.22% | 91 |
|
|
2022
Q1 | $11.3M | Hold |
43,475
| – | – | 0.17% | 119 |
|
|
2021
Q4 | $9.55M | Sell |
43,475
-8,919
| -17% | -$1.73M | 0.13% | 151 |
|
|
2021
Q3 | $9.5M | Buy |
52,394
+142
| +0.3% | +$27.7K | 0.12% | 167 |
|
|
2021
Q2 | $10.5M | Buy |
52,252
+250
| +0.5% | +$52.3K | 0.13% | 156 |
|
|
2021
Q1 | $11.2M | Sell |
52,002
-6,351
| -11% | -$1.39M | 0.15% | 136 |
|
|
2020
Q4 | $13.8M | Sell |
58,353
-3,810
| -6% | -$874K | 0.18% | 118 |
|
|
2020
Q3 | $16.9M | Sell |
62,163
-531
| -0.8% | -$146K | 0.24% | 80 |
|
|
2020
Q2 | $18.2M | Buy |
62,694
+2,777
| +5% | +$753K | 0.28% | 72 |
|
|
2020
Q1 | $14.3M | Buy |
59,917
+905
| +2% | +$208K | 0.27% | 80 |
|
|
2019
Q4 | $12.9M | Hold |
59,012
| – | – | 0.2% | 109 |
|
|
2019
Q3 | $10M | Sell |
59,012
-344
| -0.6% | -$60.9K | 0.17% | 141 |
|
|
2019
Q2 | $10.9M | Sell |
59,356
-258
| -0.4% | -$45.1K | 0.18% | 122 |
|
|
2019
Q1 | $11M | Buy |
59,614
+805
| +1% | +$149K | 0.19% | 114 |
|
|
2018
Q4 | $9.74M | Sell |
58,809
-26,850
| -31% | -$4.65M | 0.19% | 115 |
|
|
2018
Q3 | $16.5M | Buy |
85,659
+6,050
| +8% | +$1.08M | 0.2% | 116 |
|
|
2018
Q2 | $13.5M | Hold |
79,609
| – | – | 0.17% | 137 |
|
|
2018
Q1 | $13M | Buy |
79,609
+817
| +1% | +$133K | 0.17% | 141 |
|
|
2017
Q4 | $11.8M | Buy |
78,792
+1,200
| +2% | +$178K | 0.15% | 157 |
|
|
2017
Q3 | $11.8M | Hold |
77,592
| – | – | 0.16% | 149 |
|
|
2017
Q2 | $10M | Buy |
77,592
+100
| +0.1% | +$12K | 0.14% | 171 |
|
|
2017
Q1 | $8.47M | Buy |
77,492
+1,800
| +2% | +$158K | 0.12% | 190 |
|
|
2016
Q4 | $5.58M | Buy |
75,692
+2,000
| +3% | +$163K | 0.09% | 265 |
|
|
2016
Q3 | $6.43M | Buy |
73,692
+1,600
| +2% | +$151K | 0.1% | 224 |
|
|
2016
Q2 | $6.2M | Hold |
72,092
| – | – | 0.1% | 230 |
|
|
2016
Q1 | $5.73M | Hold |
72,092
| – | – | 0.1% | 234 |
|
|
2015
Q4 | $9.07M | Buy |
72,092
+2,100
| +3% | +$254K | 0.16% | 142 |
|
|
2015
Q3 | $7.29M | Buy |
69,992
+1,760
| +3% | +$226K | 0.14% | 173 |
|
|
2015
Q2 | $8.43M | Buy |
68,232
+200
| +0.3% | +$25.2K | 0.15% | 167 |
|
|
2015
Q1 | $8.03M | Buy |
68,032
+1,000
| +1% | +$120K | 0.14% | 173 |
|
|
2014
Q4 | $7.96M | Buy |
67,032
+188
| +0.3% | +$21.2K | 0.14% | 172 |
|
|
2014
Q3 | $7.51M | Hold |
66,844
| – | – | 0.14% | 172 |
|
|
2014
Q2 | $6.33M | Buy |
66,844
+3,000
| +5% | +$210K | 0.12% | 204 |
|
|
2014
Q1 | $4.51M | Buy |
63,844
+1,420
| +2% | +$112K | 0.09% | 263 |
|
|
2013
Q4 | $4.64M | Buy |
+62,424
| New | +$4.35M | 0.09% | 245 |
|
Other funds holding VRTX
VCM
VPM
Gulf International Bank (UK)'s VRTX Position: Q1 2026 in Review
Gulf International Bank (UK) increased its Vertex Pharmaceuticals (VRTX) stake by 52% in Q1 2026, buying an estimated $3.13M and bringing the position to 19,636 shares worth $8.77M. The position accounts for 0.2% of the portfolio, ranked #92.
Gulf International Bank (UK) first reported a position in VRTX in Q4 2013 and has held it in 50 quarters since. The position peaked at $18.2M in Q2 2020. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Gulf International Bank (UK) held 19,636 shares of Vertex Pharmaceuticals worth $8.77M as of Q1 2026.
- Gulf International Bank (UK) bought 6,720 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.13M.
- Vertex Pharmaceuticals made up 0.2% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #92 holding.
- Gulf International Bank (UK) first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- Gulf International Bank (UK)'s Vertex Pharmaceuticals position peaked at $18.2M in Q2 2020.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.